Literature DB >> 12214279

Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo.

Yi-Qing Chen1, Yong-Qing Zhou, James H Fisher, Ming-Hai Wang.   

Abstract

RON, a member of the MET proto-oncogene family, has been implicated in the progression of certain epithelial cancers. The purpose of this study was to determine the oncogenic potential of RON in vivo in lung epithelial cells. Transgenic mice were established using surfactant protein C promoter to express human RON in the distal lung epithelial cells. These mice were born normal but developed multiple lung tumors with distinct morphology and growth patterns. Tumors appeared as a single mass in the lung around 2 months of age and gradually developed into multiple nodules located mostly in the peripheral portions of the lung. A transition from early adenomas to later adenocarcinomas was observed. Morphologically, tumors were characterized as cuboidal epithelial cells with a type II cell phenotype, grew along the alveolar walls, and projected into the alveolar septa. RON was highly expressed and constitutively activated in tumors. These results indicate that overexpression of human wild-type RON causes the formation of lung tumors with unique biological characteristics in vivo. This model provides opportunities to study the role of RON in the pathogenesis of lung tumors and to elucidate the mechanisms underlying this distinct lung tumor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214279     DOI: 10.1038/sj.onc.1205783

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus.

Authors:  Alla Danilkovitch-Miagkova; Fuh-Mei Duh; Igor Kuzmin; Debora Angeloni; Shan-Lu Liu; A Dusty Miller; Michael I Lerman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

2.  Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.

Authors:  Rebecca J McClaine; Aaron M Marshall; Purnima K Wagh; Susan E Waltz
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

Review 3.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

4.  Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway.

Authors:  Ami S Bhatt; Alana Welm; Christopher J Farady; Maximiliano Vásquez; Keith Wilson; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-27       Impact factor: 11.205

5.  Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.

Authors:  Patricia M LoRusso; Mrinal Gounder; Shadia I Jalal; Valérie André; Siva Rama Prasad Kambhampati; Nick Loizos; Jennifer Hall; Timothy R Holzer; Aejaz Nasir; Jan Cosaert; John Kauh; E Gabriela Chiorean
Journal:  Invest New Drugs       Date:  2017-02-04       Impact factor: 3.850

6.  An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells.

Authors:  Hsiao-Sheng Liu; Pei-Yin Hsu; Ming-Derg Lai; Hong-Yi Chang; Chung-Liang Ho; Hong-Lin Cheng; Hsing-Ta Chen; Yan-Ju Lin; Tsung-Jung Wu; Tzong-Shin Tzai; Nan-Haw Chow
Journal:  Carcinogenesis       Date:  2010-05-24       Impact factor: 4.944

7.  The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

Authors:  Alana L Welm; Julie B Sneddon; Carmen Taylor; Dimitry S A Nuyten; Marc J van de Vijver; Bruce H Hasegawa; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

Review 8.  Ron-receptor tyrosine kinase in tumorigenesis and metastasis.

Authors:  Mike A Leonis; Megan N Thobe; Susan E Waltz
Journal:  Future Oncol       Date:  2007-08       Impact factor: 3.404

9.  Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers.

Authors:  Jocelyn Logan-Collins; Ryan M Thomas; Peter Yu; Dawn Jaquish; Evangeline Mose; Randall French; William Stuart; Rebecca McClaine; Bruce Aronow; Robert M Hoffman; Susan E Waltz; Andrew M Lowy
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

10.  The Ron receptor promotes prostate tumor growth in the TRAMP mouse model.

Authors:  M N Thobe; J K Gray; D Gurusamy; A M Paluch; P K Wagh; P Pathrose; A B Lentsch; S E Waltz
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.